Vol.
81,
April
28,1978
No.
4, 1978
BIOCHEMICAL
AND
LABtLING
OF
AMP-ADP
SITtS
BY 5’-p-FLUOROSULf-
Tag
2
RESEARCH
COMMUNICATIONS Pages
AFFINITY
1
BlOPHYSlCAL
Department
Mansourl
of Chemistry,
March
14,
PHOSPHOFRUCTOKINASL
ONYLBLNZOYL
and
of Pharmacology, Stanford,
Department
Received
t.
IN HtART
ADtNOSINt
Roberta
Stanford California
University
1370-1376
F. Colman2
University 94305
School
of Delaware,
of Medicine,
Newark,
Delaware
19711
1978
SUMMARY: The purine nucleotide derivative, 5’-p-fluorosulfonylbenzoyl adenosine (5’FSO B Ado) functions as an affinity label for the allosteric sites of phosphofructokinage . ’ The modified enzyme at pH 6.9 is insensitive to allosteric inhibition by ATP, activation by AMP, c-AMP, ADP and shows no sigmoidal kinetics for fructose-6-P. The reaction does not appear to occur at the catalytic site since modification of the enzyme does not significantly affect its specific activity nor its Michaelis constant at pH 8.2. ADP, and to a much lesser degree AMP and ATP, protects the enzyme from modification by the adenosine reagent. The modified enzyme essentially does not bind significant amounts of AMP, c-AMP, ADP, but still binds an analog of ATP, AppNHp. The adenosine affinity label will be of value in studies on the nature of the AMP-ADP allosteric sites.
Phosphofructokinase at neutral AMP
or
and
sites
the
through residue
However,
the
we
have
adenine
*
nature
binding found
that
(FSB-adenine)*
FSB-adenine
refers
the
from
of to
labels
a regulatory
site
adenine reacts
the
analog covalently
the
sites
and
allosteric
at pH
6.9
while
enzyme).
their
photooxidation
relationship
have to
provides
a
more
prior
covalent
reaction
0006-29lX/78/0814-137O$Ol.oo/o 1370
sheep
heart
been the
the made
catalytic of (Z-5).
effective
way
(6,7,8).
Recently, benzylthiol]
phosphofructokinase
benzylthio]
for
groups
8-[m-(m-fluorosulfonylbenzamido) with
and
modification
sulfhydryl
generally to its
sites
chemical
with
cyclic
inhibition
Attempts
(11,
reaction
Both
kinetics AMP,
of allosteric
sites.
and
or
8.2
presence
catalytic
to 8-[m-(m-fluorosulfonylbenzamido)
Copyright 0 I978 by Academic Press, Inc. All rights of reproduction in any form reserved.
at pH
enzyme
of the
anhydride
affinity
the
basis
by
ethoxyformic
the
“deinhibit”
allosteric
modification
by use
(or
on the
separate
kinetics
inhibits
inhibition
of
specific
histidine
selectively
are
order
ATP
explained
that
first
pH.
ATP
been
ligands
elucidate
acidic
relieve
have
modifier to
slightly
ADP
deinhibition
exhibits
adenine.
making
of
Vol. 81, No. 4, 1978
it
less
and
sensitive
ADP
AMP
inhibition
by
Modification
ADP
adenosine site
rabbit
muscle
modifier
of
binding.
A new
present
specific adenosine
**
bovine pyruvate of
investigation affinity reagents
in exploring
the
for exhibit
AMP-ADP
by this
shown
Since
whether
AMP-ADP
binding
(8)
sites chemical
the
and
of
is FSB-adenine,
that
reduction
of
reagent
label
of the
inhibitory
the
Mg-ADP
site
closely we
make
related have
Both both
of
to the
undertaken
functions
in phosphofructokinase. features
AMP
Y-p-fluorosulfonylbenzoyl
is more
adenosine
cyclic
a marked
as an affinity
5’-FS02BZAdo than
by AMP,
causes
derivative,
dehydrogenase
(IO).
different
reagent
to act
phosphofructokinase
the
to activation
nucleotide
been
to evaluate
label
insensitive
enzyme
glutamate
kinase
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
and
purine
has
liver
nucleotides
ATP
of the
(5’-FS02BZAdo)
DPNH
the
to
(9).
and
BIOCHEMICAL
as a more adenine
of them
and
of value
sites.
METHODS: Sheep heart phosphofructokinase was purified and crystallized as described before (11, 12). Methods for solubilizing the crystalline enzyme and for assaying at pH 6.9 in imidazole buffer and at pH 8.2 in glycylglycine buffer were those described in previous investigations (9, 11, 12). The reagent 5’-FS02EZAdo was synthesized from adenosine and 5’-p-fluorosulfonylbenzoyl chloride by the method of Wyatt and Colman (10). It was dissolved in absolute ethanol 4and-lits lconcentration was determined spectrophotometrically at 259 nm (E= 1.35 x 10 cn M- ). For the determination of the C labelled sample of the reagent was amount of 5’-FSO B -adenosine bound to PFi&a prepared by the id&ion of 100 uCi of [8C] adenosine to nonlabeled adenosine (5 mmoles) prior to reaction with 5’-p-fluorosulfonylbenzoyl chloride. For a typical experiment to modify the enzyme and to measure the incorporation of the adenosine reagent, the enzyme (0.9 mg per ml) was incubated with the reagent at a final concentration of 50 uM for one hour in the presence of 100 uM of phosphate buffer pH 8.0 and 1 mM of EDTA. The concentration of ethanol in the reaction mixture was 4-6%. At the end of this period, the reaction was stopped by adding concentrated mercaptoethanol to bring the final concentration to 44mM. A control sample of the enzyme was treated exactly the same way without adding the adenosine reagent. In order to measure the amount of the reagent that binds covalently to the enzyme, the modified enzyme was dialyzed twice against 500 volumes of a solution containing 50 mM sodium phosphate buffer at pH 7.2 and 0.1% SDS for one hour and overnight against For preparation of a stock batch of modified 3000 volumes of the same dialysis buffer. enzyme, 5.4 mg of modified enzyme in 6 ml of buffer solution was precipitated by adding powdered ammonium sulfate (0.38 gm per ml) immediately following enzyme modification by the reagent. The precipitate was centrifuged at 12000 xg for 10 min and the residue was suspended in 1 ml of 50 mM phosphate buffer (pH 8.0) containing 100 uM ATP, 10 uM fructose-1,6-P2, 1 mM EDTA and 1 mM dithiothreitol. To this enzyme solution was added, slowly, an equal volume of 100% room temperaturesaturated ammonium sulfate at pH 7.8 and O”, with constant stirring. The suspension was stored at 4OC overnight. The enzyme was then centrifuged at 7000 xg for 10 min. The residue was suspended in 50 mM phosphate buffer (pH 8.0) containing 100 uM ATP, 10 uM fructose-1,6-P , 50 mM DTT and 50% saturated ammonium sulfate. The enzyme can be stored in this i! orm for months.
**
5’-FS02BZAdo
refers
to 5’-p-fluorosulfonylbenzoyl
1371
adenosine.
Vol. 81, No. 4, 1978
RESULTS
AND
reaction
DISCUSSION:
of the
from
0.96
BIOCHEMICAL
enzyme
to
1.16
of
reagent
was
not
protein
was
indicated
solution
the
did
the
6.9.
of
however,
hand,
ATP
AMP.
that
the
is
that
the
native
the
modified
curves,
however,
shown).
Modified
enzyme
investigated
App(NH)p
ADP
against
being
caused
almost
protect
the
enzyme
SDS
the
dialysis
marked
difference
than
to activation
by
enzyme
and
from
ATP
modification
inhibition.
against
1372
modification
At and
with results
at concentrations activiation.
For
fructose-6-phosphate
the
pH
caused ADP
caused
by the
reagent
Fructose-6-phosphate, reagent.
ATP.
(data
not
pH (6.5).
reactivity
8.2
AMP
of
kinetics
AMP
by the
other
AMP The
at an acidic on
0.5
of 1 mM
concentrations
protection. while
AMP
no sigmoidal
native
ATP
enzyme.
the
inhibitory
6.9,
of
of
the
or presence
to AMP on
show
On
effect
native
presence
up to a level
the
at
becomes
In the
enzyme.
the
examined
enzyme
absence
nucleotides
at pH
was
uM.
native
velocity
complete
to ATP
to
constants,
inhibition
insensitive
different
modification
desensitized
of
enzyme
that
enzyme
the
Michaelis
modified
illustrate
of
stable of
I shows
the
2
presence
more
maximum with
the
no
as 700
in the
initial
modified
Table
of
the
inhibition
of
influence
chemical
Protection
did not
is also
inhibits
is completely
the
of the
the
5’-FSD2BZAdo.
from
in
ATP
is sensitive
dependence
varied
bound
inhibition
that
from
enzyme
60%
showed
as high
Fig.
enzyme
sigmoidal
Titration
while
cause
covalently against
to ATP
1 show
ATP
enzyme
the
Fig.
is protected
in
ATP
enzyme
concentrations
summarized
concentration
enzyme
at
8.2,
The
incubation
“Methods”).
pH
that
enzyme.
and modified in
of
was
dialysis
under at
(13)
modified
enzyme,
protection.
native
reagent
hr
after
a value
= 90,000).
one
exhaustive
plots
enzyme
inhibit
the
gave
(MW
following
(see
the
while
protection
reagent
ATP
native
of
protection
the
not
native
with
that
summarized
results
8.2
of radioactivity
by dialysis
protomer
That
concentrations
as 10 uM
We
pH
at higher does
concentrations
fact
native
to
the
per
at
the
the
both
results
The
as low
and
of
AMP
mM,
show
by
insensitive
1 mM
reagent
Lineweaver-Burk
The
completely
the
incorporation
followed
changed.
release
Sensitivity pH
of
measured
modified
of the
5’-FS02BZAdo
significantly
from
between
with
enzyme
not
determined
Measurement
mole
velocity
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
of only caused only
PFK
partial good partial
prevents
the
citrate,
and
BIOCHEMICAL
Vol. 81, No. 4, 1978
AND 8IOi’HYSlCAL
RESEARCH COMMUNICATIONS
0.7 0.6 t
2 z
0.5-
8 d a4a. .z -0 0.33 0.2 0.1 01
0
I 0.1
I
I
I
I
I
0.2
0.3 [ATPI
0.4
0.S
0.6
I
0.7
mt.4
I 0.2
02
I 0.4
1 0.6
to inhibition by were prepared as was measured at 6.9 without AMP fructose-6-P was
Fig. 2. Sensitivity of native (a) and modified 0) phosphofructokinase to activation AMP. Enzyme activity was measured at pH 6.9 in the presence of 0.25 mM ATP, mM fructose-6-P and 1 mM MgC12
Protection Incorporation Nucleotide
5FS02BZAdo
Incorporated
by 0.5
I
by Nucleotides
of [14C]-5’-FS02BZAdo
I I.0
[AMPI mM
Fig. 1. Sensitivity of native (A) and modified 0 phosphofructokinase ATP. Enzyme modified by 5-FSBO B -adenosine and native enzyme described under “Methods .” Imti* *a? ve4 ocity of phosphofructokinase different ATP concentrations in the regular reaction mixture at pH (straight line) or with 1 mM AMP (dashed lines). The concentration of fixed at 0.5 mM and the MgC12 at I mM.
TABLE
I ae
Against by Phosphofructokinasea
(Mole/mole
Phosphofructokinase)
pH 6.9
pH 8.0 None
0.97
1.01
5mM ATP
0.83
0.49
5mM ADP 5mM AMP
0.21 0.71
0.17 0.49
‘Reaction of the enzyme with the adenosine reagent was carried out for I hour as described under Methods except that the various nucleotides were added to the reaction mixture as indicated. The buffers used were 100 mM of potassium phosphate at pH 8.0, or pH 6.9 with 1 mM EDTA.
1373
Vol. 81, No. 4, 1978
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
r
h
\E E I 15
\
0.8
0.7
Q6
0;5-
a4-
0.3 -
0.2 o.l-s, - 0
0
04
0
02
The Figs.
of
3, 4 and
modified AMP not
effect
5 show
enzyme. and
0.9
bind
mole
to
modified
enzyme
do
imidoanalog, modified
of
The
differ
results
was of
is functioning
per
is
mole
not
the
0.s
1.0
the
shown).
one
binding
to
The class In
to the
native
Affinity
enzyme
binding
of
of sites
the
5).
as to the
0.65
to Binding
binding for
mole
native of ADP
and of
App(NH)p
native an by
low. the
present as
investigation
an affinity
label
1374
suggest
for the
that
allosteric
5’-p-fluorosulfonylbenzoyl sites
of does
the
modified
of
binding
examined.
essentially ADP
(Fig.
amount of
was
binds
cto
binding
as well
enzyme
contrast,
maximal
PFK
AMP native
to
0 phosphofructokinase. value for c-AMP
Modified
nucleotide.
in
06
phosphofructokinase, for AMP binding
native
enzyme.
abolished.
significantly
ADP
that
more than
almost
(data
c-AMP,
show
either
indicates
and
App(NH)p enzyme
adenosine
amounts
enzyme
not
plots
AMP
(0) value
on nucleotide
of AMP,
Scatchard
of cyclic
sigificant
is not linear
binding
0.4
(A) and modified 5 to 50 PM. KD
modification
the
The
enzyme the
enzyme
w\,
Moles Cyclic AMP Bound per Mole Enzyme
Fig. 3. Binding of AMP to native (4) and modified concentrations were varied from 5 to 50 uM. K,, enzyme was 4.87 MM. Fig. 4. Binding of cyclic AMP to native AMP concentrations were varied from native enzyme was 0.72 uM.
,
of phosphofructo-
ATP the
Vol. 81, No. 4, 1978
BIOCHEMICAL
Moles
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
0.6 ADP Bound
1.2
0.6 1.0 per Mole Enzyme
1.4
ADP
Fig. 5. Binding of ADP to native (Is) and modified (0) phosphofructokinase. concentrations were varied from 4.5 to 112.8 uM. K value for ADP high of native enzyme was 0.82 pM and 12.4 pM for low a9. fimty * sites.
kinase. the
Reaction enzyme
supports
does the
is different are by
similar the
does
from
catalytic
appreciably
bind
inhibition
by
allosteric
site.
initial
capable
enzyme protection
by
or
its
c-AMP:
on
ADP.
possibility
provide
inhibitory
analog)
not
of the
of the effect
at a distinct
that
modified
inhibitor, marked
1375
and
two
by
types
the
even
if
the
cannot
the
enzyme addition
reaction
provide
exclude
of of the
appreciable sites seem
might
to
inhibitory
altered
of allosteric
not
it
the
deinhibitors)
it does
is occupied
is insensitive
since
by 5’-FS02BZAdo
enzyme
and
does
ADP
a hyperbolic
against
ADP
result
and
site
within
protection
The
site
site.
AMP
exhibits
since
of
This
modified
enzyme
ATP,
dehibitor
occupied
ATP
for
allosteric
modification
reagent.
of added
site
to be excluded
deinhibitor
8.2.
concentration the
the
pH
enzyme
sites
modification
of the
the
modified
the
In contrast,
and
allosteric
in which
seems
since at
properties
a direct
does
inhibitor
the
the
Since
postulate
incorporation
activity
that
the
of
mixture
site
fructose-6-phosphate
or
might
catalytic
specific
enzyme
an analogue
the
the
native
ADP
the
Moreover,
of binding
Occupation
eliminate (or
for
5’-FS02BZAdo.
distinguishable.
of ATP
(1,2)
this
against
occupied
previously
However,
reaction
with
at its
AMP
one
occur
significantly
velocity
c-AMP,
ATP,
to
site.
expected AMP,
of
to
the
to those
to the
affect reported
deinhibitors
is still
appear
evidence
dependence
ATP
not
not
affinity
(that to
be expected the
binding
be
Vol. 81, No. 4, 1978
BIOCHEMICAL
The present better
affinity
tested
previously
AMP
reagent,
label (9).
addition
to
The extent
orientation
the
affinity
sites
following
ribose
label
than
moiety
will
its analog
reagent must
moiety be of value
may be considered FSB-adenine
to ATP inhibition
modification
the adenine
RESEARCH COMMUNICATIONS
adenosine,
of desensitization
of the fluorosulfonylbenzoyl
and the adenosine ADP allosteric
following
adenine,
5’-fluorosulfonylbenzoyl
for the AMP-ADP
and ADP was complete
was less extensive
AND BIOPHYSICAL
by the adenosine (9). play
It therefore
an important
of the affinity in studies
label.
a
which
was
and activation
by
reagent
while
it
appears
that
in
role
for
optimal
Both the adenine
on the nature
of the AMP-
sites.
ACKNOWLEDGEMENT: We wish to thank Miss Linda Lan for her excellent technical assistance. This investigation was supported by U.S.P.H.S. Grant HL17976 and American Cancer Society Grant B.C.-138. REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13.
Ahlfors, C.E., and Mansour, T.E. (1969), J. Biol. Chem. 244, 1247-1251. Setlow, B., and Mansour, T.E. (19701, J. Biol. Chem. *724-5533. Kemp, R.G. (19691, Biochemistry g, 4&91-4496. Younathan, E.S., Paetkau, V., and Lardy, H.A. (19681, J. Biol. Chem. 243, 1603-1608. Froede, H.C., Geraci, G., and Mansour, T.E. (19681, J. Biol. Chem. 243, 6021-6029. Anderson, R.A., and Graves, D.J. (1973), Biochemistr 12, 1895-1906. 2, Anderson, R.A., Parrish, R.F., and Graves,-$,8’iochemistry 1901-1906. Paf, P.K., Wechter, W.J., and Colman, R.F. (1975),-J. 3iol. Chem. 250, 8140-8147. Mansour, T.E. and Martensen, T.M. (19781, J. Biol. Chem. (In Press). Wyatt, J.L. and Colman, R.F. (19771, Biochemistr 16 1333-1342. Mansour, T.E., Wakid, N., and Sprouse, ---?-+-’ H.M. 1966, J. Biol. Chem. 3, 1512-1521. Lorenson, M.Y., and Mansour, T.E. (1969), J. Biol. Chem. 244, 6420-6431. Mansour, T.E. and Ahlfors, C.E. (19681, J. Biol. Chem.. 243, 2523-2533.
1376